Catherine Miller Sanders

机构：Adaptive Biotechnologies (United States) · ORCID：0000-0001-5058-0486

发表论文 132 篇 · 总被引 6051 次 · h-index 25

代表论文

• Large-Scale Post-Transplant TCR Deep Sequencing Reveals a Major T Cell Diversity Bottleneck with Post-Transplant Cyclophosphamide with Implications for Both Efficacy and Toxicity: Results of the BMT CTN 1801 Study (2023 · Blood · 被引 12)
• Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant (2025 · medRxiv · 被引 8)
• Lessons Learned From 7 Years of Implementing Cervical Cancer Screening and Treatment in Equatorial Guinea (2025 · JCO Global Oncology · 被引 1)
• Supplementary Figure from Anti-spike T-cell and Antibody Responses to SARS-CoV-2 mRNA Vaccines in Patients with Hematologic Malignancies (2023 · 被引 1)
• Combined TCR-seq and single-cell RNA-seq reveal distinct origins for antiviral immunity after post-transplant cyclophosphamide and tac/MTX gvhd prophylaxis: Results from the BMT CTN 1801 study (2025 · Blood)
• Data from The Combined Effect of FGFR Inhibition and PD-1 Blockade Promotes Tumor-Intrinsic Induction of Antitumor Immunity (2023)